Glaxosmithkline and Pfizer merge healthcare bunisesses in £10 Billion Deal

2 Business Giants, Glaxosmithkline (68%) and Pfizer (32%) have merged theit businesses together to become the world’s biggest supplier of Over-the-Counter Medicines.

The new merger will generate revenues worth £9.8 Billion. As a result, GSK’s share prices have gone up 7% as at Wednesday, 19/12/2018.

The merger will affect some jobs as GSK will have to split in two segments; a part to cater for the over-the-counter medicine and the other part to research new vaccines and pharmaceutical products.